<unk>  in indicated for the treatment of people aged 12 years and older with chronic graft-versus-host disease (chronic GVHD) after failure of at least two prior lines of systemic therapy.
Belumosudil
Nicogel
Lesinurad
Vagisil
Degmacyte
Ladostigil
Lazaretto
Brodifacoum